Source: Boston University
Date: August 7, 2007
Summary:
(Boston) – Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain (AL) Amyloidosis, a condition that occurs when plasma cells in bone marrow produce proteins that misfold and deposit in tissues, leading to organ failure and death.
